BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,045 filers reported holding BAXTER INTL INC in Q4 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $179,718 | +52.3% | 4,762 | +245.3% | 0.00% | +50.0% |
Q4 2021 | $118,000 | 0.0% | 1,379 | -5.8% | 0.00% | 0.0% |
Q3 2021 | $118,000 | +47.5% | 1,464 | +47.1% | 0.00% | 0.0% |
Q2 2021 | $80,000 | -97.7% | 995 | -97.5% | 0.00% | -97.7% |
Q1 2021 | $3,407,000 | +56683.3% | 40,390 | +53753.3% | 0.09% | – |
Q4 2020 | $6,000 | -100.0% | 75 | -100.0% | 0.00% | -100.0% |
Q3 2017 | $115,723,000 | -12.2% | 1,844,179 | -15.3% | 0.40% | -8.6% |
Q2 2017 | $131,878,000 | +25.0% | 2,178,364 | +7.1% | 0.43% | +34.2% |
Q1 2017 | $105,482,000 | +58.2% | 2,033,936 | +35.3% | 0.32% | +49.8% |
Q4 2016 | $66,676,000 | +192.7% | 1,503,760 | +214.2% | 0.22% | +190.5% |
Q3 2016 | $22,781,000 | +179.5% | 478,598 | +165.6% | 0.07% | +138.7% |
Q2 2016 | $8,150,000 | +60.9% | 180,198 | +46.1% | 0.03% | +29.2% |
Q1 2016 | $5,066,000 | -69.3% | 123,321 | -71.5% | 0.02% | -68.8% |
Q4 2015 | $16,506,000 | -27.3% | 432,666 | -37.4% | 0.08% | -31.9% |
Q3 2015 | $22,690,000 | +229.7% | 690,667 | +287.4% | 0.11% | +253.1% |
Q2 2015 | $6,881,000 | -49.9% | 178,287 | -11.1% | 0.03% | -47.5% |
Q1 2015 | $13,742,000 | -18.3% | 200,611 | -14.8% | 0.06% | -15.3% |
Q4 2014 | $16,817,000 | +7.4% | 235,381 | +7.9% | 0.07% | +7.5% |
Q3 2014 | $15,654,000 | +4.4% | 218,100 | +5.1% | 0.07% | +6.3% |
Q2 2014 | $14,999,000 | -13.6% | 207,461 | -12.1% | 0.06% | -10.0% |
Q1 2014 | $17,365,000 | -8.0% | 235,990 | -13.1% | 0.07% | -10.3% |
Q4 2013 | $18,880,000 | -11.3% | 271,446 | -16.2% | 0.08% | -16.1% |
Q3 2013 | $21,276,000 | – | 323,891 | -1.0% | 0.09% | – |
Q2 2013 | $0 | – | 327,152 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 41,000,000 | $2,482,140,000 | 22.00% |
THUNDERBIRD PARTNERS LLP | 1,711,643 | $103,623,000 | 12.17% |
SECTOR GAMMA AS | 1,070,333 | $64,798,000 | 9.42% |
Veritas Asset Management LLP | 10,179,102 | $616,243,000 | 4.81% |
13D Management LLC | 194,807 | $11,794,000 | 4.18% |
Progressive Investment Management Corp | 78,316 | $4,741,000 | 3.69% |
Aristotle Capital Management, LLC | 6,846,307 | $414,476,000 | 3.46% |
ARGENT CAPITAL MANAGEMENT LLC | 1,394,075 | $84,397,000 | 3.37% |
Lipe & Dalton | 80,073 | $4,848,000 | 3.14% |
PURA VIDA INVESTMENTS, LLC | 125,000 | $7,568,000 | 3.00% |